Overview:
Pliomyelitis is caused by poliovirus and is highly infectious disease. It is commonly known as polio or infantile paralysis. The poliovirus comes from Enterovirus genus, which is a single-stranded RNA virus. Poliovirus has three types of serotypes, P1, P2, and P3 and developing immunity to one serotype does not help to fight other serotypes. The virus gets transmitted primarily through the fecal-oral route by consuming contaminated water or food and rarely through oral-oral route. The disease can be spread for up to six weeks by those who are infected by the virus even if there are no symptoms. After a week of infection, the virus colonizes the gastrointestinal tract, oropharynx, and intestine, by invading local lymphoid tissue and entering bloodstream, it can infect central nervous system cells. When the virus replicates in motor neurons of the anterior horn and brain system, it results into destruction of cell causing manifestation of poliomyelitis. There are two types of vaccines developed for protection from the virus, Oral poliovirus vaccine (OPV), which is given orally and Inactivated poliovirus vaccine (IPV), which is administered through an injection.
Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/380
Drivers:
The wild polio infection where still occurs in 3 countries, Nigeria, Pakistan, and Afghanistan, which is expected to boost growth of the polio vaccines market over the forecast period.
Since 1999, no cases of indigenous wild poliovirus type 2 has been detected. In 2015, the World Health Assembly suggested that the Member States that are using OPV currently, should be prepared for global withdrawal of type 2 OPV component in April 2016. As per the World Health Organization, member countries need to add at least 1 IPV dose in routine immunization schedule.
In 2014, the UNICEF awarded Bilthoven Biologicals/ Serum Institute of India and Sanofi Pasteur for supplying IPV in 1, 5, and 10 dose vials, and long term supply agreements were formed through 2018.
Since 2000, procurement of UNICEF OPV has reached 1.8 billion doses per year. In May 2013, at the World Health Assembly, GPEI introduced the “End Game Strategic Plan 2013-2018”. This strategy aims to eliminate wild and vaccine-derived polio incidences through programs of routine immunization to gradually replace OPV use with IPV vaccine, which in turn is expected to fuel growth of the global polio vaccines market in coming future.
Children under 5 years of age are mostly affected by polio. Around 70% of infections of poliovirus in children show no symptoms and 25-30% infections generic sickness with no symptoms or laboratory evidence of invading central nervous system. Such factors are making the organization to focus on the vaccines options to make prophylactic approach for preventing the disease, and this is expected to boost growth of the polio vaccine market in coming future.
The statistic of occurrence of polio disease is expected to drive growth of the global polio vaccine market. The market depends on 1% of polio cases that can turn into paralytic polio causing paralysis in the brainstem (bulbar polio), the spinal cord (spinal polio), or both. As reported by the WHO, 1 out of 200 infections turns into permanent paralysis, and it causes 5 to 10 % deaths among those paralyzed individuals due to immobilization of breathing muscles.
Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/380
Restraints:
In 1994, America was declared polio free. In 2004, Australia, China, and other 37 Pacific nations were also declared to be polio free. From 2011, no cases of wild polio infection were registered. These factors are expected to hamper growth of the global polio vaccines market in the coming future.
Market taxonomy:
By product:
-
IPV
-
OPV
By end user:
-
Hospital
-
Clinics
-
Public Services
-
Others
Key players:
Key players active in the global polio vaccine market include Bibcol, Bio-Med, Adithya Vaccine Pharma, IPOLand Aventis Pasteur, Merck & Co, Pfizer, Beijing Tiantan Biological, Panacea Biotec Ltd, Sinovac Biotech Ltd, Bio Farma, GlaxoSmithKline (GSK) and Sanofi Pasteur.
Reasons to Purchase this Report
• Current and future of global Polio Vaccines Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!!!!!!!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Purchase This Premium Report With Discounted Rate @ https://www.coherentmarketinsights.com/insight/buy-now/380
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Polio Vaccines Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Polio Vaccines Industry Impact
Chapter 2 Global Polio Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Polio Vaccines (Volume and Value) by Type
2.3 Global Polio Vaccines (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Polio Vaccines Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Polio Vaccines Market Analysis
Chapter 6 East Asia Polio Vaccines Market Analysis
Chapter 7 Europe Polio Vaccines Market Analysis
Chapter 8 South Asia Polio Vaccines Market Analysis
Chapter 9 Southeast Asia Polio Vaccines Market Analysis
Chapter 10 Middle East Polio Vaccines Market Analysis
Chapter 11 Africa Polio Vaccines Market Analysis
Chapter 12 Oceania Polio Vaccines Market Analysis
Chapter 13 South America Polio Vaccines Market Analysis
Chapter 14 Company Profiles and Key Figures in Polio Vaccines Business
Chapter 15 Global Polio Vaccines Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837